Differential predictors of medication adherence in HIV: Findings from a sample of African American and caucasian HIV-positive drug-using adults

AIDS Patient Care and STDs

Volumn 26, Issue 10, 2012, Pages 621-630

  Thames, April D ^a,d   Moizel, Jennifer ^b   Panos, Stella E ^a,d   Patel, Sapna M ^a,d   Byrd, Desiree A ^c   Myers, Hector F ^a   Wyatt, Gail E ^a   Hinkin, Charles H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COGNITION; DEPRESSION; DISEASE COURSE; DRUG ABUSE; DRUG USE; EDUCATIONAL STATUS; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH LITERACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PATIENT COMPLIANCE; PATIENT SATISFACTION; SOCIAL CARE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; COGNITION DISORDERS; DEPRESSION; DRUG USERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MEDICATION ADHERENCE; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; SOCIAL SUPPORT; UNITED STATES;

EID: 84867004145     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0157     Document Type: Article

References (64)

1. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active anti-retroviral therapy adherence and HIV-1 RNA viral load. J Acquir Immune Defic Syndr 2006;43:S23-S35. (Pubitemid 44885639)
2. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003;37:1112-1118. (Pubitemid 37323668)
3. Osborn C, Paasche-Orlow M, Davis T, Wolf M. Health literacy: an overlooked factor in understanding HIV health disparities. Am J Prev Med 2007;33:374-378. (Pubitemid 47575812)
4. Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 Infected individuals. AIDS Behav 2007;11:185-194.
5. Waldrop-Valverde D, Jones DL, Gould F, Kumar M, Ownby RL. Gender differences in medication management capacity in HIV infection: The role of health literacy and numeracy. AIDS Behav 2009;13:46-52.
6. Hinkin CH, Barclay T, Castellon SA, et al. Medication adherence among HIV1 adults: Effects of cognitive dysfunction and regimen complexity. Neurology 2002;59:1944-1950. (Pubitemid 36076569)
7. Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 1999;91:439-446.
8. Durant RW, McClure L, Halanych J, et al. Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the Regards Study. Ethn Dis 2010;20:282-289.
9. Giordano T, Bartsch G, Zhang Y, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDs 2010;24:287-295.
10. Centers for Disease Control and Prevention. Subpopulation estimates from the HIV Incidence Surveillance System\United States, 2006. Morb Mortal Wkly Rep 2008;57:985-989.
11. Saha S, Freeman M, Toure J, et al. Racial and ethnic disparities in the VA health care system: A systematic review. J Gen Intern Med 2008; 23:654-671.
12. Malta M, Magnanini MMF, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS Behav 2010;14:731-47.
13. Knowlton A, Arnsten J, Eldred L, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection DU. J Acquir Immune Defic Syndr 2006;41:486-492.
14. Sankar A, Neufeld S, Berry R, Luborsky M. Cultural rationales guiding medication adherence among African Americans with HIV/AIDS. AIDS Patient Care STDs 2011;25:547-555.
15. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS 2004;18:S19-S25. (Pubitemid 38365902)
16. Volkow ND, Chang L, Wang G-J, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158:377-382. (Pubitemid 32205193)
17. Reback CJ, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003;15:775-785. (Pubitemid 37494567)
18. Hinkin CH, Castellon SA, Atkinson JH, Goodkin K, et al. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol 2001;54:S44-S5.
19. Mohammed H, Kielyka L, Richardson-Alston G, et al. Adherence to HAART among HIV-infected persons in Rural Louisiana. AIDS Patient Care STDs 2004;18:289-296. (Pubitemid 38720319)
20. Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002;16:2175-2182. (Pubitemid 35387272)
21. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004;10:317-331. (Pubitemid 38779804)
22. Reger M, Welsch R, Razani J, Martin DJ, Boone K. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002;8:410-424. (Pubitemid 34296099)
23. Thames AD, Kim M, Becker B, et al. Medication and finance management among HIV-infected adults: The impact of age and cognition. J Clin Exp Neuropsychol 2010;6:1-10.
24. Albert SM, Weber CM, Todak G, et al. An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication outcomes. AIDS Behav 1999;3:121-128. (Pubitemid 29316238)
25. Hinkin CH, Barclay T, Castellon SA, et al. Medication adherence among HIV1 adults: Effects of cognitive dysfunction and regimen complexity. Neurology 2002;59:1944-1950. (Pubitemid 36076569)
26. Ettenhofer M, Foley J, Castellon SA. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology 2010;74:1217-1222.
27. Waldrop-Valverde D, Osborn C, Rodriguez A, Rothman R, Kumar M, Jones D. Numeracy skills explain racial differences in HIV medication management. AIDS Behav 2010; 4:799-806.
28. Davis TC, Wolf MS, Bass PF, et al. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med 2010;21:847-851. (Pubitemid 44024931)
29. Wolf MS, Davis TC, Shrank W, et al. To err is human: Patient misinterpretations of prescription drug label instructions. Patient Educ Couns 2007;67:293-300. (Pubitemid 46990725)
30. Osborn C, Paasche-Orlow M, Davis T, Wolf M. Health literacy: an overlooked factor in understanding HIV health disparities. Am J Prev Med 2007;33:374-378. (Pubitemid 47575812)
31. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001;158:725-730. (Pubitemid 32429839)
32. Valente SM. Depression and HIV disease. Assoc Nurses AIDS Care 2003;14:41-51. (Pubitemid 38543322)
33. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001;58:721-728. (Pubitemid 32717795)
34. Rabkin J, Ferrando S, van Gorp W, et al. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. J Neuropsychiatry Clin Neurosc 2000;12:451-457.
35. Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2005;38:320-328. (Pubitemid 40333499)
36. Starace F, Ammassari A, Trotta MP, et al. Cognitive and affective disorders associated to HIV infection in the HAART era: Findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The Neu-roICONA study. Acta Psychiatr Scand 2002;106:20-26. (Pubitemid 34828144)
37. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs 1999;13:185-197. (Pubitemid 29155987)
38. Applebaum AJ, Richardson MA, Brady SM, et al. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS Behav 2009;13:60-65.
39. Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status. Health Psychol 2007;26:40-49. (Pubitemid 46072023)
40. Lehavot K, Huh D, Walters KL, King KM, Andrasik M, Simoni J. AIDS Patient Care STDs 2011;25:181-189.
41. Knowlton AR, Yang C, Bohnert A, Wissow L, Chander G, Arnsten JA. Informal care and reciprocity of support are associated with HAART adherence among men in Baltimore, MD, USA. AIDS Behav 2011;15:1429-1436.
42. Darbes, L. A., & Lewis, M. A. (2006). HIV-specific social support predicts less sexual risk behavior in gay male couples. Health Psychology, 24, 617-622. (Pubitemid 41698171)
43. Halbert, C.H. Armstrong, K., Gandy, O.H., Jr, Shaker, L., 2006. Racial differences in trust in health care providers. Archives of Internal Medicine, 166, 896-901.
44. Bogart LM, Thorburn S., 2005. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? J Acquir Immune Defic Syndr; 38:213-218. (Pubitemid 40189330)
45. Saha, S., Jacobs, E., Moore, R., & Beach, M., 2010. Trust in physicians and racial disparities in HIV care. AIDS Patient Care And Stds, 24(7), 415-420.
46. Lewis, L., Askie, P., Randelman, S., et al., 2010. Medication Adherence Beliefs of Community-Dwelling Hypertensive African Americans. Journal of Cardiovascular Nursing, 25, 3, 199-206.
47. Lee YY, Lin JL. The effects of trust in physician on self-efficacy, adherence and diabetes outcomes. Soc Sci Med 2009;68:1060-1068.
48. Godin G, Cote J, Naccache H, Lambert LD, Trottier S. Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS Care 2005;17:493-504. (Pubitemid 40663209)
49. Schonnesson LN, Williams ML, Ross MW, et al. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease. International journal of STD & AIDS 2007;18:369-373. (Pubitemid 351738975)
50. Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndrome (in press).
51. Grober E, Sliwinski M. Development and validation of a model for estimating premorbid verbal intellect in the elderly. J Clin Exp Neuropsychol 1991;13:933-949.
52. Beck AT. Beck Depression Inventory: Manual. San Antonio, TX: Psychological Corporation, 1987.
53. Myers H, Durvasula F, Ramani S. Psychiatric disorders in African American men and women living with HIV/AIDS. Cultur Divers Ethnic Minor Psychol 1999;5:249-262. (Pubitemid 29382089)
54. Marshall GN, Hays RD. The Patient Satisfaction Questionnaire (Short-Form; PSQ-18). Santa Monica, CA: RAND.
55. Halkitis P, Palamar J, Mukherjee P. Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care STDs 2008;22:323-335. (Pubitemid 351562967)
56. Oh DL, Sarafian F, Silvestre A, et al. Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort. J Acquir Immune Defic Syndr 2009;52:290-293.
57. Sullivan PS, Campsmith ML, Nakamura GV, Begley EB, Schulden J, Nakashima AK. Patient and regimen characteristics associated with self-reported nonadherence to anti-retroviral therapy. PloS One 2007;2:e552.
58. Lillie-Blanton M, Brodie M, Rowland D, et al. Race, ethnicity, and the health care system: Public perceptions and experiences. Med Care Res Rev 2000;57(Suppl 1):218-235.
59. Godin G, Cote J, Naccache H, Lambert LD, Trottier S. Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS Care 2005;17:493-504. (Pubitemid 40663209)
60. Bird ST, Bogart LM. Perceived race-based and socioeco-nomic status (SES)-based discrimination in interactions with health care providers. Ethn Dis 2001;11:554-563. (Pubitemid 33584378)
61. Street RL, O'Malley KJ, Cooper LA, et al. Understanding concordance in patient-physician relationships: Personal and ethnic dimensions of shared identity. Ann Fam Med 2008;6:198-205. (Pubitemid 351716778)
62. Galvan FH, Davis M, Banks D, Bing E. HIV stigma and social support among African Americans. AIDS Patient Care STDs 2008;22:423-436. (Pubitemid 351733238)
63. Hamilton JB, Moore CE, Powe BD, Agarwal M, Martin P. Perceptions of support among older African American cancer survivors. Oncol Nurs Forum 2010;37:484-493
64. Gonzalez JS, Safren SA, Cagliero E. et al. Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity. Diabetes Care 2007;30:2222-2227. (Pubitemid 47359018)